WEST PHARMACEUTICAL SERVICES INC - 8-K Filing
West Pharmaceutical Services raises full-year 2026 net sales and adjusted EPS guidance following Q3 results exceeding expectations. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $WST